Cover Image
市場調查報告書

手術用人工血管:醫療設備的開發平台評估

Vascular Grafts - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 346859
出版日期 內容資訊 英文 86 Pages
訂單完成後即時交付
價格
Back to Top
手術用人工血管:醫療設備的開發平台評估 Vascular Grafts - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年08月04日 內容資訊: 英文 86 Pages
簡介

本報告提供手術用人工血管的開發中產品調查分析,以各開發階段比較分析為焦點,提供開發中產品的開發中主要企業,進行中的臨床試驗相關資訊等系統性資訊。

第1章 目錄

第2章 簡介

  • 手術用人工血管概要

第3章 開發中的產品

  • 手術用人工血管 - 開發中產品:各開發階段
  • 手術用人工血管 - 開發中產品:各地區
  • 手術用人工血管 - 開發中產品:各法規
  • 手術用人工血管 - 開發中產品:各核准預定日
  • 手術用人工血管 - 進行中的臨床試驗

第4章 手術用人工血管 - 正在開發的開發中產品:各企業

  • 手術用人工血管企業 - 開發中產品:各開發階段
  • 手術用人工血管 - 開發中產品:各開發階段

第5章 手術用人工血管企業與產品概要

  • 3S BioMedical, Inc.
  • Anethon (Inactive)
  • ARISTE Medical
  • Cardiojustable LLC
  • CryoLife, Inc.
  • DSM Biomedical B.V.
  • Eqalix, Inc.
  • FIT Biotech Oy
  • Gel-Del Technologies, Inc.
  • Graftworx, LLC
  • Healionics Corporation
  • Innovia LLC
  • MultiGene Vascular Systems (MGVS) Ltd.
  • NuVascular Technologies Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • SurgaColl Technologies Ltd
  • Universidad de Los Andes
  • VesselTek BioMedical LLC
  • Xeltis AG

第6章 手術用人工血管 - 最近的趨勢

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0411EPD

GlobalData's Medical Devices sector report, "Vascular Grafts - Medical Devices Pipeline Assessment, 2017" provides an overview of Vascular Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vascular Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Vascular Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vascular Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vascular Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 6

2 Introduction 7

  • 2.1 Vascular Grafts Overview 7

3 Products under Development 8

  • 3.1 Vascular Grafts - Pipeline Products by Stage of Development 8
  • 3.2 Vascular Grafts - Pipeline Products by Segment 9
  • 3.3 Vascular Grafts - Pipeline Products by Territory 10
  • 3.4 Vascular Grafts - Pipeline Products by Regulatory Path 11
  • 3.5 Vascular Grafts - Pipeline Products by Estimated Approval Date 12
  • 3.6 Vascular Grafts - Ongoing Clinical Trials 13

4 Vascular Grafts - Pipeline Products under Development by Companies 14

  • 4.1 Vascular Grafts Companies - Pipeline Products by Stage of Development 14
  • 4.2 Vascular Grafts - Pipeline Products by Stage of Development 16

5 Vascular Grafts Companies and Product Overview 17

  • 5.1 3S BioMedical, Inc. Company Overview 17
    • 5.1.1 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.2 Ariste Medical LLC Company Overview 19
    • 5.2.1 Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.3 C. R. Bard Inc Company Overview 20
    • 5.3.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.4 Cardiojustable LLC (Inactive) Company Overview 24
    • 5.4.1 Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.5 Colorado Therapeutics, LLC Company Overview 25
    • 5.5.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.6 CryoLife Inc Company Overview 26
    • 5.6.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.7 DSM Biomedical BV Company Overview 27
    • 5.7.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.8 Eqalix Inc Company Overview 28
    • 5.8.1 Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.9 FIT Biotech Oy Company Overview 30
    • 5.9.1 FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.10 Gel-Del Technologies, Inc. Company Overview 32
    • 5.10.1 Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.11 Graftworx, LLC Company Overview 33
    • 5.11.1 Graftworx, LLC Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.12 Healionics Corporation Company Overview 34
    • 5.12.1 Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.13 Humacyte Inc Company Overview 35
    • 5.13.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.14 Innovia LLC Company Overview 39
    • 5.14.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.15 Northwestern University Company Overview 40
    • 5.15.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.16 NuVascular Technologies Inc Company Overview 41
    • 5.16.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.17 PetVivo Holdings Inc Company Overview 42
    • 5.17.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.18 RegenaGraft Company Overview 43
    • 5.18.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.19 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 44
    • 5.19.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.20 SurgaColl Technologies Ltd Company Overview 45
    • 5.20.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.21 Universidad de Los Andes Company Overview 46
    • 5.21.1 Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.22 University of Louisville Company Overview 47
    • 5.22.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.23 Vascutek Ltd Company Overview 48
    • 5.23.1 Vascutek Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.24 VesselTek BioMedical LLC Company Overview 49
    • 5.24.1 VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.25 VESSL Therapeutics Ltd Company Overview 51
    • 5.25.1 VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.26 Xeltis AG Company Overview 52
    • 5.26.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 52

6 Vascular Grafts- Recent Developments 53

  • 6.1 Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%) 53
  • 6.2 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 53
  • 6.3 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 55
  • 6.4 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 56
  • 6.5 Jul 07, 2017: MPSC New COO Glendy Wang on Board 57
  • 6.6 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 57
  • 6.7 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 59
  • 6.8 Apr 27, 2017: Fit Biotech: Appointments in Fit Biotech's Management 60
  • 6.9 Apr 26, 2017: LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%) 61
  • 6.10 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results 61
  • 6.11 Apr 23, 2017: Bard Announces First Quarter Results 62
  • 6.12 Apr 03, 2017: Retrospective Study Confirms Bovine Carotid Artery Biologic Graft Outperforms Expanded Polytetrafluoroethylene for Hemodialysis Access 63
  • 6.13 Mar 30, 2017: FIT Biotech: Appointment to FIT Biotech's Management Team 63
  • 6.14 Mar 30, 2017: MPSC Announces 2016 Annual Results 64
  • 6.15 Feb 21, 2017: LeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%) 66
  • 6.16 Feb 15, 2017: CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results 66
  • 6.17 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 67
  • 6.18 Jan 26, 2017: Bard Announces Fourth Quarter Results 68
  • 6.19 Jan 16, 2017: SurgaColl Technologies: Board Announcement - Appointment of CEO 69
  • 6.20 Dec 29, 2016: Humacyte Commences U.S. Phase II Arterial Bypass Clinical Trial 69
  • 6.21 Nov 03, 2016: DSM Q3 2016 Results 70
  • 6.22 Nov 01, 2016: Xeltis Announces Multidisciplinary Scientific Advisory Board of Global Leading Experts 72
  • 6.23 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 73
  • 6.24 Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results 75
  • 6.25 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 76
  • 6.26 Oct 25, 2016: James W. Bullock Joins CryoLife Board of Directors 76
  • 6.27 Oct 25, 2016: Bard Announces Third Quarter Results 77
  • 6.28 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 77
  • 6.29 Sep 16, 2016: Federal Circuit Court of Appeals upholds LifeNet Health's $34.7 million patent victory 78
  • 6.30 Sep 14, 2016: Fit Biotech Oy's Half-year Financial Report January 1-June 30, 2016 78
  • 6.31 Sep 06, 2016: CryoLife Appoints James McDermid as Chief Human Resources Officer 80
  • 6.32 Aug 30, 2016: MPSC Announces 2016 Interim Results 80

7 Appendix 83

  • 7.1 Methodology 83
  • 7.2 About GlobalData 86
  • 7.3 Contact Us 86
  • 7.4 Disclaimer 86

List of Tables

1.1 List of Tables

  • Table 1: Vascular Grafts - Pipeline Products by Stage of Development 8
  • Table 2: Vascular Grafts - Pipeline Products by Segment 9
  • Table 3: Vascular Grafts - Pipeline Products by Territory 10
  • Table 4: Vascular Grafts - Pipeline Products by Regulatory Path 11
  • Table 5: Vascular Grafts - Pipeline Products by Estimated Approval Date 12
  • Table 6: Vascular Grafts - Ongoing Clinical Trials 13
  • Table 7: Vascular Grafts Companies - Pipeline Products by Stage of Development 14
  • Table 8: Vascular Grafts - Pipeline Products by Stage of Development 16
  • Table 9: 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 10: Resorpor AdvaMatrix Micro Small Vessel Graft - Product Status 17
  • Table 11: Resorpor AdvaMatrix Micro Small Vessel Graft - Product Description 17
  • Table 12: Resorpor AdvaMatrixrPro Vessel Graft - Product Status 18
  • Table 13: Resorpor AdvaMatrixrPro Vessel Graft - Product Description 18
  • Table 14: Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 15: Drug Eluting Vascular Graft - Product Status 19
  • Table 16: Drug Eluting Vascular Graft - Product Description 19
  • Table 17: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 18: Covera Vascular Covered Stent Graft - Product Status 20
  • Table 19: Covera Vascular Covered Stent Graft - Product Description 21
  • Table 20: Lifestream Stent Graft - Product Status 21
  • Table 21: Lifestream Stent Graft - Product Description 21
  • Table 22: C. R. Bard Inc - Ongoing Clinical Trials Overview 22
  • Table 23: Lifestream Stent Graft - A Prospective, Multi-center, Non-randomized, Single-arm Study of the Bard Lifestream Balloon Expandable Vascular Covered Stent in the Treatment of Iliac Artery Occlusive Disease: BOLSTER 23
  • Table 24: Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 25: Adjustable SPA Shunt - Product Status 24
  • Table 26: Adjustable SPA Shunt - Product Description 24
  • Table 27: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 28: Xenograft Implant - Peripheral Vascular Disease - Product Status 25
  • Table 29: Xenograft Implant - Peripheral Vascular Disease - Product Description 25
  • Table 30: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 31: Synergraft Xenograft Vascular Graft - Product Status 26
  • Table 32: Synergraft Xenograft Vascular Graft - Product Description 26
  • Table 33: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 34: Small Diameter Vascular Graft - Product Status 27
  • Table 35: Small Diameter Vascular Graft - Product Description 27
  • Table 36: Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 37: CardioVessel - Product Status 28
  • Table 38: CardioVessel - Product Description 28
  • Table 39: LCL Graft - Product Status 29
  • Table 40: LCL Graft - Product Description 29
  • Table 41: FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 42: GTU X-Graft - Product Status 30
  • Table 43: GTU X-Graft - Product Description 30
  • Table 44: GTU X2-Graft - Product Status 31
  • Table 45: GTU X2-Graft - Product Description 31
  • Table 46: Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 47: VasoGraft - Product Status 32
  • Table 48: VasoGraft - Product Description 32
  • Table 49: Graftworx, LLC Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 50: Smart Graft - Product Status 33
  • Table 51: Smart Graft - Product Description 33
  • Table 52: Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 53: STARgraft - Vascular Reconstruction - Product Status 34
  • Table 54: STARgraft - Vascular Reconstruction - Product Description 34
  • Table 55: Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 56: HAV Graft - Vascular Trauma - Product Status 35
  • Table 57: HAV Graft - Vascular Trauma - Product Description 35
  • Table 58: HUMACYL - Peripheral Artery Disease - Product Status 36
  • Table 59: HUMACYL - Peripheral Artery Disease - Product Description 36
  • Table 60: Humacyte Inc - Ongoing Clinical Trials Overview 37
  • Table 61: HUMACYL - Peripheral Artery Disease - A Phase 2 Study for the Evaluation of Safety and Efficacy of Humacytes Human Acellular Vessel for Use as a Vascular Bypass or Interposition Vessel in Patients with Limb-threatening Peripheral Arterial Trauma 38
  • Table 62: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 63: 4mm Vascular Graft - Product Status 39
  • Table 64: 4mm Vascular Graft - Product Description 39
  • Table 65: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 66: ePTFE Graft - Peripheral Arterial Disease - Product Status 40
  • Table 67: ePTFE Graft - Peripheral Arterial Disease - Product Description 40
  • Table 68: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 69: BioFunc - APC Vascular Graft - Product Status 41
  • Table 70: BioFunc - APC Vascular Graft - Product Description 41
  • Table 71: PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 72: Peripheral Vascular Graft - Product Status 42
  • Table 73: Peripheral Vascular Graft - Product Description 42
  • Table 74: RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 75: RegenaVasc - Product Status 43
  • Table 76: RegenaVasc - Product Description 43
  • Table 77: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 78: Enhanced Vascular Graft - Product Status 44
  • Table 79: Enhanced Vascular Graft - Product Description 44
  • Table 80: SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 81: CardioColl - Product Status 45
  • Table 82: CardioColl - Product Description 45
  • Table 83: Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 84: SiSgraft - Product Status 46
  • Table 85: SiSgraft - Product Description 46
  • Table 86: University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 87: Vascular Graft System - Product Status 47
  • Table 88: Vascular Graft System - Product Description 47
  • Table 89: Vascutek Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 90: Triplex Advanced Vascular Graft - Product Status 48
  • Table 91: Triplex Advanced Vascular Graft - Product Description 48
  • Table 92: VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 93: VTek Graft - Product Status 49
  • Table 94: VTek Graft - Product Description 49
  • Table 95: VTek-RA Wrap - Product Status 50
  • Table 96: VTek-RA Wrap - Product Description 50
  • Table 97: VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 98: MultiGeneGraft - Product Status 51
  • Table 99: MultiGeneGraft - Product Description 51
  • Table 100: Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 101: Endogenous Tissue Growth Implant - Product Status 52
  • Table 102: Endogenous Tissue Growth Implant - Product Description 52
  • Table 103: Glossary 85

List of Figures

1.2 List of Figures

  • Figure 1: Vascular Grafts - Pipeline Products by Stage of Development 8
  • Figure 2: Vascular Grafts - Pipeline Products by Segment 9
  • Figure 3: Vascular Grafts - Pipeline Products by Territory 10
  • Figure 4: Vascular Grafts - Pipeline Products by Regulatory Path 11
  • Figure 5: Vascular Grafts - Pipeline Products by Estimated Approval Date 12
  • Figure 6: Vascular Grafts - Ongoing Clinical Trials 13
Back to Top